311 related articles for article (PubMed ID: 15910290)
41. An overview of the heparin-induced thrombocytopenia syndrome.
Warkentin TE
Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
[TBL] [Abstract][Full Text] [Related]
42. Dabigatran use in a postoperative coronary artery bypass surgery patient with nonvalvular atrial fibrillation and heparin-PF4 antibodies.
Fieland D; Taylor M
Ann Pharmacother; 2012 Jan; 46(1):e3. PubMed ID: 22202498
[TBL] [Abstract][Full Text] [Related]
43. Heparin induced thrombocytopenia.
Gupta S; Gupta MM
J Assoc Physicians India; 2008 Aug; 56():622-7. PubMed ID: 19051709
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
Mattioli AV
Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
[TBL] [Abstract][Full Text] [Related]
45. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates.
Khairy M; Lasne D; Brohard-Bohn B; Aiach M; Rendu F; Bachelot-Loza C
Thromb Haemost; 2001 Jun; 85(6):1090-6. PubMed ID: 11434690
[TBL] [Abstract][Full Text] [Related]
46. [Heparin-induced thrombocytopenia: implictions for cardiologist].
Mattioli AV
G Ital Cardiol (Rome); 2006 Oct; 7(10):675-83. PubMed ID: 17171989
[TBL] [Abstract][Full Text] [Related]
47. Generation of antibodies to heparin-PF4 complexes without thrombocytopenia in patients treated with unfractionated or low-molecular-weight heparin.
Amiral J; Peynaud-Debayle E; Wolf M; Bridey F; Vissac AM; Meyer D
Am J Hematol; 1996 Jun; 52(2):90-5. PubMed ID: 8638647
[TBL] [Abstract][Full Text] [Related]
48. Detection and significance of heparin-platelet factor 4 antibodies.
Francis JL
Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
[TBL] [Abstract][Full Text] [Related]
49. [Heparin-induced thrombocytopenia].
Gruel Y; Regina S; Pouplard C
Rev Prat; 2006 Apr; 56(7):710-8. PubMed ID: 16739902
[TBL] [Abstract][Full Text] [Related]
50. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia.
Bream-Rouwenhorst HR; Hobbs RA
Pharmacotherapy; 2008 Nov; 28(11):1401-7. PubMed ID: 18957000
[TBL] [Abstract][Full Text] [Related]
51. Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin.
Selleng K; Selleng S; Raschke R; Schmidt CO; Rosenblood GS; Greinacher A; Warkentin TE
Am J Hematol; 2005 Mar; 78(3):188-92. PubMed ID: 15726594
[TBL] [Abstract][Full Text] [Related]
52. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
Selleng K; Warkentin TE; Sheppard JA; Greinacher A
Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
[TBL] [Abstract][Full Text] [Related]
53. Pseudo-pulmonary embolism as a sign of acute heparin-induced thrombocytopenia in hemodialysis patients: safety of resuming heparin after disappearance of HIT antibodies.
Hartman V; Malbrain M; Daelemans R; Meersman P; Zachée P
Nephron Clin Pract; 2006; 104(4):c143-8. PubMed ID: 16902310
[TBL] [Abstract][Full Text] [Related]
54. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
[TBL] [Abstract][Full Text] [Related]
55. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
56. Heparin-induced thrombocytopenia: frequency and pathogenesis.
Greinacher A
Pathophysiol Haemost Thromb; 2006; 35(1-2):37-45. PubMed ID: 16855345
[TBL] [Abstract][Full Text] [Related]
57. Heparin induced thrombocytopenia in patients with ventricular assistance device bridge-to-transplantation. A case series.
Nocera P; Thiranos JC; Steib A; Morelli U
Minerva Cardioangiol; 2008 Dec; 56(6):697-701. PubMed ID: 19092745
[TBL] [Abstract][Full Text] [Related]
58. Antigens involved in heparin-induced thrombocytopenia.
Amiral J
Semin Hematol; 1999 Jan; 36(1 Suppl 1):7-11. PubMed ID: 9930557
[TBL] [Abstract][Full Text] [Related]
59. A mouse model for heparin-induced thrombocytopenia.
Blank M; Eldor A; Tavor S; Ziporen L; Cines DB; Arepally G; Afek A; Shoenfeld Y
Semin Hematol; 1999 Jan; 36(1 Suppl 1):12-6. PubMed ID: 9930558
[TBL] [Abstract][Full Text] [Related]
60. The incidence and implications of anti-heparin-platelet factor 4 antibody formation in a pediatric cardiac surgical population.
Mullen MP; Wessel DL; Thomas KC; Gauvreau K; Neufeld EJ; McGowan FX; Dinardo JA
Anesth Analg; 2008 Aug; 107(2):371-8. PubMed ID: 18633010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]